Three lenses on one programme. Use the audience tabs to switch between Vice-Chancellor, TTO, and Corporate Sponsor perspectives. Click a question to expand.
Strategic positioning, research income, and how the programme moves institutional metrics.
For each opportunity the university wishes to pursue, the Catalyst R&D Workbench produces a structured problem definition, an independently validated solution, a development roadmap, a use-case portfolio, drafted patent applications stress-tested against prior art, an equipment plan, a recruitment posting set, an 80/20 sweet-spot plan, and an aggregated portfolio review. The conversation with corporate sponsors moves from "would you fund this exploratory study?" to "here is a defensible programme of strategic value to your business: would you co-develop it?"
Higher fee income from research, materially larger corporate sponsorships, more grants won, a faster IP-to-licensing pathway, and a step change in the strategic visibility of the research portfolio. PhD positions can be embedded in funded programmes with clearly defined use cases and corporate counterparts, rather than recruited speculatively.
For Russell Group institutions and their European equivalents, where industry research income is increasingly a defining institutional metric, this is a credible mechanism for moving up the table without waiting for a generational expansion in the academic base. Existing strengths in research excellence become commercially legible at scale for the first time.
No. Cascade operates on opportunities the university chooses to pursue, framed by the academic team's existing research strengths. The programme produces evidenced proposals; the university retains complete authority over which opportunities to develop, which sponsors to engage with, and how the research is conducted.
Cascade augments rather than replaces. The research office and TTO continue to operate within their existing remit; Cascade provides the proposition-quality and validation layer that today is the binding constraint on conversion of research excellence into corporate-grade investment cases.
First validated programme proposals within weeks of programme launch. First sharper corporate-sponsor conversations and grant submissions within the first quarter. Measurable impact on research income and licensing pipeline visible across one to two academic years of consistent operation.
Positively. Senior academics increasingly evaluate institutions on the support infrastructure available for translational research. A university that can offer Workbench-grade proposition development as part of the research environment offers a differentially attractive proposition.
How Cascade supports the TTO's remit on industrial partnerships, licensing, and commercialisation.
It replaces speculative pitching with targeted, fully scoped programme proposals. Each proposal arrives validated, IP-investigated, roadmap-scoped, and use-case mapped, equivalent to months of internal R&D scoping completed before the conversation begins. Corporate sponsors engage at the level of co-development rather than scoping-study sponsorship.
Each Workbench-derived filing is investigated through the three-layer equivalence matrix (structural, functional, outcome) before submission, with novelty and freedom-to-operate verdicts attached. The TTO sees a stronger evidence base for filing decisions, and the licensing position that emerges is materially more defensible.
Materially. Filings emerge with novelty and freedom-to-operate verdicts already attached, with the licensing pathway identifiable from the moment the filing is made rather than discovered later. The IP estate accumulates as a portfolio of stress-tested filings rather than a sequence of individually-defended ones.
Yes. External IP counsel work from a structurally stronger starting position rather than from scratch, refining and extending an evidence base that is already structured. Aggregate external IP cost typically falls while filing quality typically rises.
Supportively. KEF measures research-related income from business, IP and commercialisation, and partner engagement: exactly the dimensions Cascade is designed to move. A spin-out portfolio that converts to investor funding faster, captures stronger IP positions, and engages credibly with corporate partners moves the metrics KEF tracks.
The TTO identifies opportunities the university wishes to pursue, provides context on existing licensing arrangements and IP ownership, and remains the primary commercial interface with corporate sponsors. The programme handles the proposition-quality and validation work the TTO does not have capacity to produce internally.
Directly. Spin-outs whose IP position has been investigated and whose proposition has been validated through Cascade arrive at the spin-out conversation with a materially stronger institutional-grade package, and can subsequently route through Crucible for the founder-side workstreams.
What you receive when engaging with a Cascade-prepared university proposal.
The proposal arrives validated, IP-investigated, roadmap-scoped, and use-case mapped, equivalent to months of internal R&D scoping completed before the conversation begins. Defensible novelty position because prior art has been examined through the three-layer equivalence matrix. The conversation moves to co-development on a compressed timeline rather than scoping a study.
Products reach market with stronger market fit because the use-case portfolio has been independently scored, with stronger IP protection because filings have been stress-tested before submission, and with a clearer pathway to market because the roadmap has been derived from the same validated evidence base. The chances of success on a co-developed programme are materially higher.
Co-ownership is framed up front rather than negotiated in arrears. The Cascade process produces an evidenced position from which structured commercial discussions can proceed. Terms are anchored on a defensible novelty position rather than on assertion.
Cost ratio is typically two to three orders of magnitude lower per programme run, and turnaround is days to weeks versus months. Beyond the economics, the coverage advantage is significant: the Workbench reasons over the full global corpus on every run.
Yes. Many corporate sponsors operate across several institutional partnerships. Cascade proposals are independently produced per opportunity, so multi-university engagement scales without process overhead.
The Workbench supports local and on-device deployment patterns, and standard NDAs apply to corporate-sponsor engagement. For sensitive strategic priorities (competitive responses, M&A scenarios, IP refreshes), this is structurally stronger than the cloud-dependent alternatives most strategy advisors operate on.
The university and the corporate sponsor work directly with one another, supported by the Cascade-produced proposition. Subsequent project execution is handled through the standard channels both parties already use.